InMed Pharmaceuticals Inc. (C:IN*CA)

Business Focus: Bio Therapeutic Drugs

INK Ultra Money Free

Latest 10 SEDI filings (by transaction date) for IN*CA within the last 6 months
[?]
Amended Filing
As of 11:59pm ET June 5th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 22/20 Jan 12/20 Sazdanoff, Catherine Direct Ownership Options 50 - Grant of options 35,000 $0.250
Jan 21/20 Jan 12/20 Cutler, Adam Direct Ownership Options 50 - Grant of options 35,000  
Jan 20/20 Jan 12/20 Garner, William James Direct Ownership Options 50 - Grant of options 35,000  
Jan 20/20 Jan 12/20 Hull, Andrew Harold Direct Ownership Options 50 - Grant of options 35,000 $0.250
Sign up or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for IN*CA within the last 6 months
[?]
Amended Filing
As of 11:59pm ET June 5th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 22/20 Jan 12/20 Sazdanoff, Catherine Direct Ownership Options 50 - Grant of options 35,000 $0.250
Jan 21/20 Jan 12/20 Cutler, Adam Direct Ownership Options 50 - Grant of options 35,000  
Jan 20/20 Jan 12/20 Garner, William James Direct Ownership Options 50 - Grant of options 35,000  
Jan 20/20 Jan 12/20 Hull, Andrew Harold Direct Ownership Options 50 - Grant of options 35,000 $0.250
Sign up or login above to see all SEDI filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider.
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $IN.CA

  • No tweets found